Dr Nicholas Shackel
|
Senior Lecturer
C39 - Royal Prince Alfred Hospital |
|
||||||||
On this page
Themes | Biographical details | Research interests | PhD & Masters' project opportunities | Honours project opportunities | Keywords
Biographical details
Dr Shackel is a clinical scientist with an established tract record in academia being the recipient of multiple awards including a NHMRC Gustav-Nossal Scholarship and a NHMRC C. J. Martin Fellowship. Dr Shackel has authored 36 publications (23 as first or last author, H factor, 12) and 4 book chapters. These have consistently been at a high academic level and resulted in 679 citations (five of these manuscripts have 164, 100, 52 and 37 citations respectively). [More...]
Research interests
To understand the molecular mechanisms regulating liver fibrosis aiming to developed novel therapeutic agents as well as developing new diagnostic investigations.
The current focus of the research group is to further understand the role of the glycoprotein CD147 in mediating basic and fundamental aspects of tissue inflammatory responses and carcinogenesis. Our group has made the fundamental discovery that CD147 mediates a process of inflammatory cell aggregation, which was previously not recognised, that mediates inflammatory responses and carcinogenesis. Taking this novel discovery from the bench through to high impact papers is the current focus of the group.
PhD and Masters' project opportunities
Mechanisms of Liver Fibrosis and Hepatocellular Carcinoma
The Role of Extracellular Matrix Metalloprotease Inducer (EMMPRIN) in Liver Disease
Stem Cells in Liver Disease
Honours project opportunities
Role of Bone-Marrow Derived Cells in Progressive Liver Injury and Carcinogenesis
Discovering Novel Biomarkers In Hepatocellular Carcinoma (HCC)
Glycosylation of Extracellular Matrix Metalloproteinase inducer (EMMPRIN) in human liver disease and the development of cirrhosis and hepatic carcinoma
The role of Extracellular Matrix Metalloproteinase inducer (EMMPRIN) mediated cell aggregation in the development of human liver injury and liver cancer.

